NuScale Power Trades Below $10. Bargain or Value Trap?

NuScale Power shares trade near $8.75, down sharply from a three-year high of $52 and after touching a low of $2, with sentiment around nuclear power driving much of the volatility. The company has regulatory approval for its small modular reactor design but has not secured a firm commercial sale; Romania's proposed six-reactor RoPower project still requires funding. NuScale remains a capital-intensive, loss-making startup facing regulatory, execution, manufacturing and delivery risks, making the stock suitable only for aggressive investors.

Analysis

SMR remains a pre-revenue duration asset rather than a conventional nuclear equity: its valuation will be driven by financing credibility, customer credit quality, and construction-risk allocation—not reactor-design approval alone. The first binding order could produce a sharp sentiment rerating over days, but a memorandum of understanding, feasibility award, or non-recourse project announcement should not be treated as equivalent; these structures often lack committed capital and can unwind before notice-to-proceed.

The key near-term issue is dilution. Without customer deposits, government-backed funding, or a strategic manufacturing partner absorbing working-capital needs, each additional development cycle raises the probability that equity issuance funds the path to commercialization. A signed project that requires NuScale to retain material EPC, schedule, or fixed-price exposure would be a mixed catalyst: it validates demand but can lower the appropriate multiple by importing the cost-overrun risk that has impaired large nuclear projects.

Competitive upside may accrue first to nuclear-adjacent incumbents rather than SMR developers. BWXT offers exposure to qualified nuclear-component manufacturing and government programs, while CEG and VST monetize rising zero-carbon power scarcity without first-of-a-kind reactor execution risk. The contrarian view is that the market may be underpricing the strategic value of an independently financed, repeatable SMR order book; however, that outcome requires evidence of standardized economics across multiple units, not merely one subsidized flagship project.

There is no compelling directional catalyst from this newsflow alone. Over the next 1-3 months, monitor cash runway, quarterly operating cash burn, customer deposits, and whether Romanian or U.S. counterparties disclose fully funded development milestones. Over 6-18 months, the thesis is falsified by incremental equity raises without firm backlog conversion, project cancellation, or contract terms that leave SMR with uncapped delivery liability.

Key Decisions for Investors

• Avoid initiating a core long in SMR ahead of independently verified, binding backlog and disclosed financing; treat any rally on preliminary agreements as a potential trim/short setup rather than confirmation of commercial demand.
• For nuclear-power exposure over 6-18 months, prefer long CEG or VST versus SMR: existing generation cash flows capture power-price and data-center demand upside while avoiding first-of-a-kind construction and dilution risk.
• Use BWXT as the higher-quality nuclear supply-chain watch/long candidate if SMR orders become funded: initiate only after a customer financing close or meaningful manufacturing award, since supplier revenue recognition will lag announcements by several quarters.
• Set an SMR event alert for a definitive contract containing customer deposits, committed project financing, delivery schedule, and liability allocation. A funded multi-unit order with limited SMR balance-sheet exposure would justify reassessing a tactical long; absent those terms, no trade.